Skip to main content

Selectively superior production of docosahexaenoic acid in Schizochytrium sp. through engineering the fatty acid biosynthetic pathways

Abstract

Background

Schizochytrium sp. is commercially used for production of docosahexaenoic acid (DHA). Schizochytrium sp. utilizes the polyketide synthase complex (PKS) and a single type I fatty acid synthase (FAS) to synthesize polyunsaturated fatty acids and saturated fatty acids, respectively. The acyl carrier protein (ACP) domains of FAS or PKS are used to load acyl groups during fatty acids biosynthesis. Phosphopantetheinyl transferase (PPTase) transfers the pantetheine moiety from Coenzyme A to the conserved serine residue of an inactive ACP domain to produce its active form.

Results

In this study, in order to improve production and content of DHA, we decreased the expression of fas, strengthened the expression of the PKS pathway, and enhanced the supply of active ACP in Schizochytrium sp. ATCC20888. Weakening the expression of fas or disruption of orfA both led to growth defect and reduction of lipid yields in the resulting strains WFAS and DPKSA, indicating that both FAS and PKS were indispensable for growth and lipid accumulation. Although WFAS had a higher DHA content in total fatty acids than the wild-type strain (WT), its growth defect and low DHA yield hinders its use for DHA production. Overexpression of the orfAB, orfC, orfC-DH (truncated orfC), or ppt promoted DHA and lipid production, respectively. The yields and contents of DHA were further increased by combined overexpression of these genes. Highest values of DHA yield (7.2 g/L) and DHA content (40.6%) were achieved in a recombinant OPKSABC-PPT, ⁓56.5% and 15.3% higher than the WT values, respectively.

Conclusions

This study demonstrates that genetic engineering of the fatty acid biosynthetic pathways provides a new strategy to enhance DHA production in Schizochytrium.

Background

Omega-3 polyunsaturated fatty acids (PUFAs), such as DHA (22:6 ω-3) and eicosapentaenoic acid (EPA, 20:5 ω-3), play important roles in promoting development of nervous system and visual system and preventing cardiovascular and cerebrovascular diseases, diabetes, and cancers, and are widely used in food additives and pharmaceutical industry [1,2,3].

In recent years, Schizochytrium sp. of thraustochytrids has attracted wide interests for its ability to accumulate significant amounts of total lipids rich in DHA [4]. Fatty acid biosynthesis in Schizochytrium sp. involves two different pathways that work independently. A single type I fatty acid synthase is responsible for saturated fatty acids (SFAs) biosynthesis (Fig. 1A). The polyketide synthase complex (PKS or PUFA synthase) is responsible for biosynthesis of DHA and docosapentaenoic acid (DPA, 22:5 ω-6) [5,6,7]. FAS contains one acyltransferase (AT), one enoyl reductase (ER), one dehydratase (DH), one malonyl-CoA: ACP acyl transferase (MAT), two acyl carrier protein (ACP), one 3-ketoacyl-ACP reductase (KR), and one 3-ketoacyl-ACP synthase (KS) domains. FAS catalyzes a set of iterative reactions where two carbons are added at each cycle, eventually producing a saturated C16 [6, 8]. The PUFA synthase complex in Schizochytrium sp. is made of 3 subunits (ORFA, ORFB, and ORFC; also known as PFA1, PFA2, and PFA3), each also harboring different multi-domains (Fig. 1A). ORFA consists of one KS, one MAT, nine ACP, one KR, and one DH domains. ORFB consists of one KS, one chain length factor (CLF), one AT, and one ER domains. ORFC consists of two DH and one ER domains [4, 5, 8]. PUFA synthase also catalyzes a set of iterative reactions that add two carbons at each cycle, while the specific mechanism how these two carbons are processed remains unclear. To be functional, PUFA synthase complex or FAS require a phosphopantetheinyl transferase (PPTase) to activate their ACPs through transferring the pantetheine moiety from Coenzyme A to the serine residues of ACPs [6, 9]. The number of tandemly repeated ACP domains in PUFA synthase has a positive correlation with its PUFA productivity [10, 11].

Fig. 1
figure 1

Schematic diagram of the fatty acid biosynthetic pathways in Schizochytrium sp. ATCC20888. A Domain organization in polyketide synthase (PKS) and fatty acid synthase (FAS) in Schizochytrium sp. ACP, acyl carrier protein; AT, acyltransferase; CLF, chain length factor; DH, dehydratase; ER, enoyl-ACP reductase; MAT, malonyl-CoA: ACP acyl transferase; KR, 3-ketoacyl-ACP reductase; KS, 3-ketoacyl-ACP synthase. B Genetic engineering of the fatty acid biosynthetic pathways for improved production of DHA in Schizochytrium sp. Gene overexpression is shown in red arrow and gene repression in green arrow

Although there is sparse detailed knowledge of the thraustochytrids PUFA synthases, various domains of the PUFA synthases are potential targets for enhancement of PUFAs productivity. Heterologous expression of orfABC genes of Schizochytrium sp. in E. coli or Yarrowia lipolytica led to accumulation of long-chain PUFAs in resulting recombinants [6, 12]. Overexpression of the KS domain of ORFA subunit from Thraustochytrium sp. ATCC26185 in E. coli improved production of SFAs effectively, while overexpression of the ORFB KS domain led to a higher ratio of unsaturated fatty acids to SFAs [13]. Disruption of the CLF domain of ORFB or the second DH domain of ORFC in Schizochytrium sp. significantly decreased PUFAs yield but slightly increased SFAs yield [14]. Overexpression of malonyl-CoA: ACP transacylase in Schizochytrium sp. increased total lipids and DHA yields by 39.60% and 81.50% in fed-batch fermentation, respectively [15]. Overexpression of an endogenous phosphopantetheine transferase gene (ppt_a) in Aurantiochytrium sp. enhanced yield and proportion of DHA by 35.5% and 17.6%, respectively [9]. Overexpression of the ORFC DH domain in Schizochytrium limacinum SR21 increased DHA and DPA contents by 9.8% and 14.8%, respectively, while overexpression of the ORFC ER domain increased SFAs content and decreased DHA and DPA contents [16]. Aurantiochytrium sp. SD116 contains two copies of fas, and DHA content in total fatty acids (TFAs) was increased from 41 to 61% through deleting a copy of fas and overexpression of acetyl-CoA carboxylase and diacylglycerol acyltransferase [17].

Schizochytrium sp. has become an emerging new model for biotechnological applications with improvements of the transformation techniques and genetic tools. In this study, we decreased the expression of fas, strengthened the expression of PPTase and three subunits of the PUFA synthase complex (ORFA, ORFB, and ORFC) in Schizochytrium sp. ATCC20888 (Fig. 1B). DHA yield and DHA content of TFAs in a recombinant OPKSABC-PPT reached 7.2 g/L and 40.6%, which were increased by 56.5% and 15.3% compared to WT, respectively. The investigation indicates that genetic engineering of the fatty acid biosynthetic pathways is an efficient way to improve DHA production in thraustochytrids.

Results

Decreased expression of fas increased DHA content but hindered growth

Saturated fatty acids (C14:0 and C16:0) of Schizochytrium are synthesized by FAS. Schizochytrium has one fas gene and deletion of the only fas gene may be lethal. In order to increase the proportion of PUFAs (especially DHA) in TFAs, we decreased expression of the fas gene by displacing its promoter with a weak promoter 4678p through homologous recombination (Fig. 2A, S1). The expression level of 4678p in WT was much lower than that of fas, especially at the time point (72 h) when lipid is rapidly accumulated (Fig. S1A). Weakening the expression of fas hindered growth, and the growth defect could be recovered by supplementation with total lipids from WT to the medium (Fig. 2B, S2).

Fig. 2
figure 2

Effects on growth, lipid accumulation, and DHA production by decreasing expression of fas. A Schematic illustration of WFAS construction. Gray arrow: weak promoter. B Dry cell weight (DCW; g/L) and lipid yield (g/L). C Lipid content (% DCW). D DHA yield (g/L) and DHA content (% TFA). Values are mean ± SD from three replicate flasks grown in fermentation medium for 120 h. E RT-qPCR analysis of transcription levels of the fatty acid biosynthetic genes in WFAS and WT. *p < 0.05, **p < 0.01, ***p < 0.001; NS, not significant (Student t test)

Lipid body staining intensity was weaker for WFAS than for WT (Fig. S3). Compared to WT, the biomass and lipid yield of the fas-weakened strain WFAS were decreased by 19.6% and 24.2% (Fig. 2B, C). Although the DHA percentage in TFAs of WFAS (40.7%) was higher than that of WT (34.1%), the DHA yield was decreased by 10.9% due to the decreased growth (Fig. 2D). RT-qPCR analysis revealed that the transcription levels of fas in WFAS were 55.0% and 44.0% of those in WT at 2 and 4 d. And the transcription levels of the PUFA synthase genes (orfA, orfB, and orfC) and the phosphopantetheine transferase gene (ppt) in WFAS were similar to or slightly lower than those in WT, which was consistent with the lipid yields of WT and WFAS (Fig. 2E). The findings indicate that decreasing the FAS pathway of Schizochytrium increases DHA content but impairs cell growth. Therefore, it is inadvisable to completely or partially disrupt the FAS pathway to improve the DHA content in Schizochytrium sp.

Insertion inactivation of orfA interrupted DHA synthesis

Decreasing the FAS pathway of Schizochytrium increases DHA content in TFAs but impairs growth and DHA yield, therefore, it is not wise to use WFAS for DHA production. Schizochytrium sp. utilizes the PKS pathway to synthesize PUFAs. In order to determine the function of PUFA synthase in fatty acid biosynthesis, we disrupted the orfA gene by inserting the selective marker bleomycin into its coding region (Fig. S4). Disruption of orfA greatly impaired growth, and supplementation with total lipids from WT also restored its growth to the WT level (Fig. 3A, S2). The orfA-inactivated mutant DPKSA produced much less lipid than WT (Fig. 3A, B, S3; Table 1).

Fig. 3
figure 3

Growth, lipid accumulation, and DHA production of WT and DPKSA. A DCW and lipid yield (g/L). B Lipid content (% DCW). C DHA yield (g/L). D Fatty acid composition (% TFA) in WT and DPKSA cultured for 120 h. *p < 0.05, **p < 0.01, ***p < 0.001 (Student t test)

Table 1 Fermentation characteristics of Schizochytrium sp. strains

DPKSA produced almost no DHA and less DPA (Fig. 3, S5), indicating that the PKS pathway is responsible for de novo synthesis of DHA and DPA, which is in accord with the previous studies [14]. The DPA percentage in TFAs of DPKSA (4.25%) was lower than WT (7.15%), suggesting that DPA synthesis depends on both FAS and PKS pathways. The proportions of C14:0 and C16:0 in TFAs of DPKSA were significantly increased. Besides, the proportions of C18:0, 18:3n–3, 20:3n–6, 20:4n–6, and EPA were also dramatically increased (Fig. 3D, S5), implying that there is a partial desaturase/elongase pathway in Schizochytrium. The silent pathway seemed to be activated in DPKSA, probably compensating for the loss of PUFAs (DHA and DPA) synthesis. Therefore, PUFA synthase plays an indispensable role in DHA synthesis and growth of Schizochytrium sp., while EPA is synthesized by FAS and the desaturase/elongase pathway.

Decreased expression of the PKS or FAS pathway impaired growth, which could be restored by addition of WT total lipids. Thin layer chromatography (TLC) analysis indicated that DPKSA and WFAS produced less TAG than WT (Fig. S6A). The PUFAs contents in TAG or phospholipids of DPKSA and WFAS resembled their PUFAs content of TFAs (Fig. S6B–E). The findings suggest that impaired growth of DPKSA and WFAS might be due to their imbalanced fatty acid composition of cell membranes, which affects membrane fluidity and stability, thereby impairing normal growth of cells. Addition of WT total lipids to the mutants exogenously compensated the corresponding fatty acid components and restored growth defect.

Overexpression of PKS or PPT increased DHA and lipid production

In order to promote the metabolic flow from SFAs synthesis towards DHA synthesis, we overexpressed the three genes (orfA, orfB, and orfC) encoding the PUFA synthase complex. orfA shares a bidirectional promoter region with orfB, since both genes are too big to handle easily in plasmids, we in situ co-overexpressed orfA and orfB through substituting their promoter regions with two ccg1 promoters in opposite directions by homologous recombination (Fig. 4A, S7). And orfC overexpression strain was constructed by introduction of an extra copy of orfC promoted by strong promoter EF1αp to chromosome (Fig. 4A). The large multifunctional ORFA of the PKS complex harbors nine multi-tandem ACP domains, and PPTase transfers the pantetheine moiety from Coenzyme A to the conserved serine residue of an inactive ACP domain to produce its active form. Therefore, ppt was overexpressed by introduction of an extra copy promoted by ccg1 promoter (Fig. 4A).

Fig. 4
figure 4

Effects on growth, lipid accumulation, and DHA production by overexpression of pks and ppt genes. A Schematic illustration of construction of overexpression strains. Bold black arrow: strong promoter. B DCW and lipid yield (g/L). C Lipid content (% DCW). D DHA yield (g/L). E RT-qPCR analysis of the overexpressed genes in OPPT, OPKSAB, and OPKSC. Statistical analyses were performed using one-way ANOVAs and Duncan’s multiple range tests. Different lowercase letters in each bar indicate a significant difference (p < 0.05) between values

The dry cell weights of these overexpression mutants (OPKSAB, OPKSC, and OPPT) were similar to that of WT (Fig. 4B). Relative to WT value (51.8%), lipid contents were much higher for OPKSAB (62.0%), OPKSC (63.1%), and OPPT (64.1%). The yields of lipid and DHA in OPKSAB (16.0 and 6.3 g/L), OPKSC (16.9 and 6.4 g/L), and OPPT (16.6 and 6.3 g/L) were significantly higher than those of WT (13.2 and 4.6 g/L) (Fig. 4B–D; Table 1). Compared to WT, the transcription levels of ppt, orfA, orfB, and orfC were significantly increased (> 1.5 fold) in respective overexpression strains, indicating that the genes were successfully overexpressed (Fig. 4E). The results indicate that overexpression of ORFAB, ORFC, and PPT enhanced lipid and DHA yields of Schizochytrium sp. The results are consistent with the previous studies that overexpression of PPT or ORFC enhanced PUFAs production of Aurantiochytrium or S. limacinum SR21 [9, 16].

Combinatorial genetic engineering for enhanced DHA and lipid production

In order to further improve DHA yield, the expression cassettes of ppt and ppt-orfC were transformed into OPKSAB or WT (Fig. 4A). Compared to WT, OPKSAB, OPKSC, and OPPT, the Nile red-based fluorescences were improved in co-overexpression strains OPKSAB-PPT, OPKSC-PPT and OPKSABC-PPT (Fig. S8). Co-expression of these genes did not affect DCWs (Fig. 5A), but promoted DHA and lipid production. The highest lipid and DHA yields (18.7 and 7.2 g/L) were achieved in OPKSABC-PPT, increased by 41.7% and 56.5% relative to WT values (Fig. 5A-C). Lipid body-staining of OPKSABC-PPT were stronger than WT, OPKSAB, OPKSC, and OPPT (Fig. 5D).

Fig. 5
figure 5

Growth, lipid accumulation, DHA production, and gene expression of WT and combined overexpression strains of pks and ppt genes. A DCW and lipid yield (g/L). B Lipid content (% DCW). C DHA yield (g/L). The different lowercase letters in each bar indicate a significant difference (p < 0.05) between values. D Confocal microscopy images of Nile red-stained cells grown in fermentation medium for 72 h. Fluorescence intensity was measured using an excitation wavelength of 488 nm (staining color: green). Bar, 25 μm. E Fatty acid composition (% TFA) in WT and OPKSABC-PPT. (F) RT-qPCR analysis of transcription levels of fatty acid biosynthetic genes in WT and OPKSABC-PPT. *p < 0.05, **p < 0.01, ***p < 0.001 (Student t test)

To determine whether overexpression of the PKS complex selectively increases DHA production, we analyzed the fatty acid composition of total lipids from OPKSABC-PPT and WT. The proportions of TFAs corresponding to DHA (40.6%) and DPA (11.0%) were higher in OPKSABC-PPT than in those of WT (DHA 35.2%; DPA 9.3%); accordingly, the proportions represented by myristic acid (C14:0) and palmitoleic acid (C16:1) were reduced in OPKSABC-PPT (Fig. 5E). The findings suggest that overexpression of PKS and PPT promotes metabolic fluxes to the PKS pathway, resulting in enhanced DHA accumulation. Although the proportions of TFAs represented by DHA and DPA were increased, the improved extent is quite small. Therefore, the transcriptional levels of key genes related to DHA and SFAs synthesis were investigated in OPKSABC-PPT and WT by RT-qPCR. The transcription levels of ppt, orfA, orfB, and orfC were greatly increased (> 1.5 fold) in OPKSABC-PPT compared with those in WT (Fig. 5F). However, the expression level of fas was also evidently increased in OPKSABC-PPT. The RT-qPCR results are consistent with enhanced DHA and lipid yields of OPKSABC-PPT. How fas is upregulated in OPKSABC-PPT needs further investigations.

ORFC contains two DH domains at N terminus and one ER domain at C terminus. Shi et al. [16] has shown that overexpression of DH domains of ORFC specifically promoted synthesis of PUFAs, while overexpression of ER domain promoted SFAs synthesis of S. limacinum SR21. Therefore, orfC-DH (truncated orfC, in which DNA encoding the ER domain was deleted) was overexpressed or co-overexpressed with ppt in WT or OPKSAB to promote DHA production (Fig. 6A). Overexpression of ORFC-DH did not affect dry cell weights of WT or OPKSAB. Compared to WT (13.2 g/L), lipid yields were significantly improved in OPKSCDH (16.1 g/L) and OPKSABCDH (16.6 g/L), especially in OPKSCDH-PPT (17.4 g/L) and OPKSABCDH-PPT (17.3 g/L) (Fig. 6B). However, their DHA yields were not selectively promoted as expected, even slightly lower than those of OPKSC-PPT and OPKSABC-PPT (Fig. 6C).

Fig. 6
figure 6

Fermentation of WT and combined overexpression strains of truncated orfC. A Schematic illustration of construction of overexpression strains. Bold black arrow: strong promoter. B DCW and lipid yield (g/L). C DHA yield (g/L)

Time course fermentation performance of the engineered strain OPKSABC-PPT

The highest DHA yield was achieved in OPKSABC-PPT. Therefore, we determined glucose utilization, biomass, lipid yield, and DHA yield profiles of OPKSABC-PPT and WT. OPKSABC-PPT had similar glucose utilization and biomass curves to WT (Fig. 7A, B). The DCWs, lipid yields, and DHA yields of both strains reached their maximum values on day 5 when glucose was almost consumed up, and deceased with further cultivation. The yields of lipid and DHA in OPKSABC-PPT on day 5 were ⁓ 41.7% and 56.5% higher than those in WT (Fig. 7C, D). The high DHA yield of OPKSABC-PPT highlights it potential for industrial application.

Fig. 7
figure 7

Fermentation curves of WT and OPKSABC-PPT. A DCW (g/L). B Glucose consumption (g/L). C Lipid yield (g/L). D DHA yield (g/L)

Discussion

In this study, DHA yield and DHA content in TFAs were increased through co-overexpression of the three subunits of PUFA synthase and PPTase in Schizochytrium sp. ATCC20888. The DHA yield of OPKSABC-PPT reached 7.2 g/L, accounting for 40.6% of TFAs, which are about ⁓56.5% and 15.3% higher than the WT values.

Various metabolic engineering strategies have been exploited to promote DHA accumulation of thraustochytrids. Aurantiochytrium sp. SD116 contains two copies of fas, and DHA content was increased from 41 to 52% by deleting a copy of fas without affecting growth, and was further increased to 61% through overexpression of acc and dgaT in ∆fas [17]. Schizochytrium sp. ATCC20888 contains only one copy of fas, and weakening the expression of fas successfully increased DHA content but seriously impaired growth, indicating that FAS is essential in Schizochytrium sp. An engineered yeast comprising EPA at 56.6% of TFAs and less than 5% SFAs has been constructed in Y. lipolytica, in which the EPA content in TAG resembled the EPA content of TFAs, while the EPA content in phospholipids was only about 22% of TFAs [18]. In this study, we found that either decreasing the expression of fas or strengthening the expression of orfABC increased DHA proportion in TFAs of Schizochytrium sp. ATCC20888, but in very small scales. In Thraustochytrium sp., very long chain polyunsaturated fatty acids (VLCPUFAs) accumulated in TAG are channeled from phosphatidylcholine, almost exclusively located at its sn-2 position, while SFAs are preferentially located at its sn-1/3 positions [19]. Although phosphatidylcholine may have either one VLCPUFA at its sn-2 position or two VLCPUFAs, lipid is mainly accumulated in the form of TAG in thraustochytrids. That is probably the reason why we couldn’t greatly improve the DHA proportion in TFAs in Schizochytrium sp. Thus, introduction of heterologous glycerol-3-phosphate acyltransferase, lysophosphatidic acid acyltransferase, and acyl-CoA: diacylglycerol acyltransferase with preference for VLCPUFA to thraustochytrids might promote DHA accumulation in TAG and enhance DHA content.

Schizochytrium sp. de novo synthesizes DHA via the PUFA synthase. Previous studies demonstrated the importance of ORFA and ORFB of the PUFA synthase in DHA production and cell growth in Schizochytrium spp. [7, 20]. In this study, overexpression of ORFA and ORFB significantly enhanced DHA accumulaiton without affecting growth. Shi’s investigation indicated that overexpression of the DH domains and ER domain of ORFC specifically promoted synthesis of PUFAs and SFAs in S. limacinum SR21, respectively [16]. However, overexpression of the DH domains of ORFC (ORFC-DH) in Schizochytrium sp. ATCC20888 displayed a slightly lower DHA yield than overexpression of the entire ORFC, especially when co-expressed with ORFAB and PPTase. So far, lack of crystal structures of the PUFA synthases limits our understanding of the processes catalyzed by these enzymes. Mammalian and fungal FAS have been demonstrated to be a 540-kDa homodimer and a 2.6-megadalton α6β6 heterododecameric complex [21, 22]. The three different subunits of the PUFA synthase may form similar giant multidomain complex like FAS, whereas the exact architecture remains to be discovered. Truncated ORFC may alter protein conformation of the PUFA synthase complex, which is unbeneficial to PUFAs synthesis. PPTase activates the ACP domains of PUFA synthase, and overexpression of PPTase significantly increased DHA and PUFA proportions in Aurantiochytrium sp. SD116 and Schizochytrium sp. HX-308 [9, 23]. Overexpression of PPTase also greatly increased DHA production and DHA proportion in Schizochytrium sp. ATCC20888, especially when co-expressed with ORFA, ORFB, ORFC, indicating that PPTase plays critical roles in DHA biosynthesis.

Thraustochytrids exploit two independent pathways (PKS and FAS) for synthesis of fatty acids, while the underlying mechanism remains to be elucidated. Mutant devoid of PUFA synthase activity displays growth defect phenotype and is auxotroph for PUFAs [7]. Here, we found that either disruption of orfA or deceasing expression of fas in Schizochytrium sp. both led to growth defect phenotype, which could be recovered by addition of total lipids from WT to culture medium, indicating that both pathways are essential for growth. Phospholipids are the principal components of cell membrane, and proportions of saturated and unsaturated fatty acids will affect fluidity, stability, and permeability of the membrane, thus affecting growth of cells [24]. DPKSA had a lower PUFAs proportion of phospholipids, while WFAS had a lower SFAs proportion of phospholipids (Fig. S6), thus, their imbalanced proportions of phospholipids are probably the reason of growth defect. The fatty acid profile of DPKSA demonstrated the existence of a silent desaturase/elongase pathway in Schizochytrium, which is activated to compensate for the loss of PUFAs synthesis in DPKSA.

Disruption of orfA led to loss of DHA synthesis and increased production of 18:3n-3, 20:3n-6, 20:4n-6, and EPA (Fig. 3D). Decreasing the expression of fas also slightly decreased the expression of orfABC in WFAS, while overexpression of orfABC genes was accompanied by a slight increase in fas expression in OPKSABC-PPT (Fig. 2E, 5F), suggesting that the synthesis of SFAs and PUFAs in Schizochytrium sp. is tightly controlled to maintain membrane homeostasis. In baker’s yeast, Mga2 senses the molecular lipid-packing density in endoplasmic reticulum membrane and adjusts membrane lipid saturation through regulating transcription of the fatty acid Δ9-desaturase Ole1 [25, 26]. Although Schizochytrium sp. possesses partial desaturase/elongase system, it synthesizes unsaturated fatty acids mainly via PUFA synthase. In our previous studies, we have identified zinc finger protein LipR and bZIP transcription factor FabR which both simultaneously represses the transcription of fatty acids synthase and PUFA synthase genes in Schizochytrium sp. [27, 28]. Therefore, systematical screening and validation of the regulators involved in lipid accumulation will help to elucidate the molecular mechanisms regulating lipid saturation and the complex regulatory networks of DHA synthesis in thraustochytrids.

Conclusion

In conclusion, we constructed an engineered strain OPKSABC-PPT with high DHA productivity and DHA content through genetic engineering of the fatty acid biosynthetic pathways. The investigation also reveals the importance of the PKS and FAS pathways for growth and lipid accumulation of Schizochytrium sp. ATCC20888. This study demonstrates that genetic engineering of the fatty acid biosynthetic pathways provides an efficient strategy to enhance PUFA production in thraustochytrids.

Materials and methods

Strains and culture conditions

The Schizochytrium and E. coli strains used for the study are listed in Table S1. Schizochytrium sp. was grown and screened on solid GPY medium containing 2% glucose, 1% peptone, 0.5% yeast extract, 1% sea crystal, and 1.5% agar. And 50 μg/mL zeocin or 400 μg/mL G418 was used for selection of transformants. The medium for seed cultivation was composed of 3% glucose, 1% peptone, 0.5% yeast extract, 2% sea crystal. Shake-flask batch fermentations for production of lipid and DHA were performed in fermentation medium containing 10% glucose, 0.5% yeast extract, 0.59% NaCl, 0.026% KCl, 0.1% (NH4)2SO4, 0.1% KH2PO4, 0.143% MgSO4, and 0.004% CaCl2. Schizochytrium sp. was cultivated at 28°C and 230 rpm in seed medium for 24 h, and then, 5% (v/v) of cultures were transferred into fermentation medium. E. coli strain JM109 was cultivated at 37°C in LB medium supplemented with 50 μg/mL zeocin or 100 μg/mL kanamycin.

Construction of mutants

The GenBank accession numbers for fas, orfA, orfB, orfC, and ppt are EF015632, AF378327, AF378328, AF378329, and PP026199 [5, 6]. Gene in situ overexpression mutant and in situ weakened mutant were constructed by homologous recombination strategy described previously [27]. For construction of orfA and orfB overexpression strain, the ble gene was amplified from plasmid pPICZaA (Invitrogen; Carlsbad, California, United States) with primers ble-o-Fw and ble-o-Rev as the selective marker and ligated with two ccg1 promoters (amplified with primers ccg1p-up-Fw/ccg1p-up-Rev and ccg1p-dw-Fw/ccg1p-dw-Rev) flanking the ble gene in opposite directions (Table S2). The upstream and downstream homologous arms flanking the orfA-orfB intergenic region were amplified from Schizochytrium sp. ATCC20888 genomic DNA with primers orfA-up-o-Fw/orfA-up-o-Rev and orfB-dw-o-Fw/orfB-dw-o-Rev and ligated with ccg1p-ble-ccg1p by seamless cloning, respectively (Fig. S7). The resulting DNA fragments were electrically transformed jointly to ATCC20888, and overexpression mutants (OPKSAB) were selected on GPY medium with 50 μg/mL zeocin. For construction of the fas-weakened mutant, the nat gene was amplified from plasmid ptrpC-Nat [29] with primers nat-loxp-Fw/nat-loxp-Rev and ligated with weak promoter 4678p (amplified with primers 4678p-Fw /4678p-Rev). The upstream and downstream homologous arms flanking the fas promoter region were amplified with primers fas-up-Fw/fas-up-Rev and fas-dw-Fw/fas-dw-Rev and ligated with nat or nat-4678p by seamless cloning, and together transformed to ATCC20888 to produce fas-weakened mutant WFAS (Fig. S1). For overexpression of orfC or ppt, the genes were amplified from the cDNA of ATCC20888 with primers orfC-Fw/orfC-Rev and ppt-Fw/ppt-Rev. The promoters and terminators of ccg1 were amplified from the Neurospora expression vector pCCG.N-3xMyc with primers ccg1p-Fw/ccg1p-Rev and ccg1t-Fw/ccg1t-Rev; EF1α promoter was amplified from Schizochytrium sp. ATCC20888 with primers ef1αp-Fw/ef1αp-Rev; and the CYC-1 terminator was amplified from pPICZαA with primers cyc1t-Fw/cyc1t-Rev. After purification, EcoRI/KpnI-digested promoter fragments and KpnI/XbaI-digested terminator fragments were ligated into EcoRI/XbaI-digested pPICZαA, respectively. The resulting plasmids were then digested with KpnI and ligated to orfC or ppt using Seamless Cloning and Assembly Kit (Clone Smarter Technologies; USA) to produce overexpression plasmids (Tables S1; S2). The expression cassettes were amplified from the corresponding overexpression plasmids and together ligated to pPIC3.5 K (Invitrogen; Carlsbad, California, United States) by seamless cloning to produce co-overexpression plasmid. After linearization by PmeI, overexpression plasmids were transformed into Schizochytrium sp. WT or OPKSAB (Fig. S9). The parameters for electroporation are 1.5 kV, 4.5 ms, twice. After incubation at 28°C for 4 h in 1 mL of seed medium, the cells were plated on GPY media with appropriate antibiotics for transformants selection.

Determination of biomass, glucose concentration, lipid yield and fatty acid composition

For biomass analysis, the cell pellets from 40 mL fermentation broth were collected by centrifugation (7000 g, 4°C, 5 min) and freeze-dried to constant weight. The glucose concentration of supernatant was detected by the 3,5-dinitrosalicylic acid method [30]. Lipid extraction and fatty acid methyl esters (FAMEs) preparation were carried out as described previously [31]. Briefly, approximately 200 mg of lyophilized Schizochytrium powder was resuspended in 6 mL of 4 M HCl and heated in a boil water bath for 30 min, and then 15 mL of methanol/chloroform (1:1, v/v) was added to extract the lipid. FAMEs were prepared from 50 mg lyophilized Schizochytrium powder and analyzed by gas chromatography as described previously [27].

Thin layer chromatography (TLC) analysis of the extracted lipid

The lipid components in the samples were determined by TLC on silica gel plate using a mobile phase consisting of n-hexane: diethyl ether: acetic acid (85:15:1; v/v/v) [32]. The separated strips were photographed by spraying MnCl2-methanol solution (0.32 g MnCl2·4H2O, 30 mL methanol, 30 mL water, and 4 mL concentrated H2SO4) in a hot air oven at 85°C for 5 min. TAG and polar lipid (PL) strips were scraped from TLC plates and then methylated using the method described previously [31]. The SFAs and PUFAs components in TAG or PL were determined by TLC on silica gel plate using a mobile phase consisting of n-hexane: diethyl ether: acetic acid (94:4:2; v/v/v). The loading amount was adjusted to load similar amounts of SFAs or PUFAs between samples. Image J software was used to detect the gray value of each lane for statistics, and SFAs of WT was set as 1.

Lipid detection and microscopic analysis by Nile red staining

The lipid production of strains can be detected directly and quickly by Nile red-based fluorescence assay [33]. Schizochytrium cells were grown in fermentation broth for 96 h. The harvested cells were collected by centrifugation (5000 g, 4°C, 5 min) and washed twice with PBS (38.7 mM Na2HPO4·12H2O, 11.3 mM NaH2PO4·2H2O, and 150 mM NaCl). Lipid was stained with Nile red dye (0.5 mg/L) in dark for 5 min. The mixtures were excited at wavelength of 488 nm and fluorescent emission was analyzed at 570 nm on a microplate reader (SpectraMax M5, Molecular devices, CA, USA). The Schizochytrium cells from 72-h-old culture were stained with Nile red dye and imaged using a LEICA TCS SP8 microscope equipped with an oil immersion objective (×1000 magnification) at 488 nm.

Quantitative real-time PCR analysis (RT-qPCR)

Total RNA was extracted from 48 or 96 h-old Schizochytrium cells using TRIzol (Tiangen; China) according to the manufacturer’s protocol. cDNA was synthesized by M-MLV (RNase H; TaKaRa Bio, Shiga, Japan) with oligo-dT18 as primers and 4 µg RNA as template. The FastStart Universal SYBR Green Master (ROX) was used for quantitative RT-PCR analysis of orfA, orfB, orfC, fas and ppt genes with primers listed in Table S2. The relative transcription level was calculated using the 2−ΔΔCt method, and actin was used as internal control.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its supplementary information files.

Abbreviations

ACP:

Acyl carrier protein

AT:

Acyltransferase

CLF:

Chain length factor

DCW:

Dry cell weight

DH:

Dehydratase

DHA:

Docosahexaenoic acid

DPA:

Docosapentaenoic acid

EPA:

Eicosapentaenoic acid

ER:

Enoyl-ACP reductase

FAMEs:

Fatty acid methyl esters

FAS:

Fatty acid synthase

KR:

3-Ketoacyl-ACP reductase

KS:

3-Ketoacyl-ACP synthase

MAT:

Malonyl-CoA: ACP acyl transferase

PKS:

Polyketide synthase

PPTase:

Phosphopantetheinyl transferase

PL:

Polar lipid

PUFAs:

Polyunsaturated fatty acids

SFAs:

Saturated fatty acids

TFAs:

Total fatty acids

TLC:

Thin layer chromatography

WT:

Wild type

References

  1. Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469–84.

    Article  CAS  PubMed  Google Scholar 

  2. Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35–43.

    Article  CAS  PubMed  Google Scholar 

  3. Zarate R, El Jaber-Vazdekis N, Tejera N, et al. Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med. 2017;6(1):25.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Chi G, Xu Y, Cao X, et al. Production of polyunsaturated fatty acids by Schizochytrium (Aurantiochytrium) spp. Biotechnol Adv. 2022;55: 107897.

    Article  CAS  PubMed  Google Scholar 

  5. Metz JG, Roessler P, Facciotti D, et al. Production of polyunsaturated fatty acids by polyketide synthases in both prokaryotes and eukaryotes. Science. 2001;293(5528):290–3.

    Article  CAS  PubMed  Google Scholar 

  6. Hauvermale A, Kuner J, Rosenzweig B, et al. Fatty acid production in Schizochytrium sp Involvement of a polyunsaturated fatty acid synthase and a type I fatty acid synthase. Lipids. 2006;41(8):739–47.

    Article  CAS  PubMed  Google Scholar 

  7. Lippmeier JC, Crawford KS, Owen CB, et al. Characterization of both polyunsaturated fatty acid biosynthetic pathways in Schizochytrium sp. Lipids. 2009;44(7):621–30.

    Article  CAS  PubMed  Google Scholar 

  8. Morabito C, Bournaud C, Maes C, et al. The lipid metabolism in thraustochytrids. Prog Lipid Res. 2019;76: 101007.

    Article  CAS  PubMed  Google Scholar 

  9. Wang S, Lan C, Wang Z, et al. PUFA-synthase-specific PPTase enhanced the polyunsaturated fatty acid biosynthesis via the polyketide synthase pathway in Aurantiochytrium. Biotechnol Biofuels. 2020;13:152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Jiang H, Zirkle R, Metz JG, et al. The role of tandem acyl carrier protein domains in polyunsaturated fatty acid biosynthesis. J Am Chem Soc. 2008;130(20):6336–7.

    Article  CAS  PubMed  Google Scholar 

  11. Hayashi S, Satoh Y, Ujihara T, et al. Enhanced production of polyunsaturated fatty acids by enzyme engineering of tandem acyl carrier proteins. Sci Rep. 2016;6:35441.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jia YL, Du F, Nong FT, et al. Function of the polyketide synthase domains of Schizochytrium sp on fatty acid synthesis in Yarrowia lipolytica. J Agric Food Chem. 2023;71(5):2446–54.

    Article  CAS  PubMed  Google Scholar 

  13. Xie X, Meesapyodsuk D, Qiu X. Ketoacylsynthase domains of a polyunsaturated fatty acid synthase in Thraustochytrium sp strain ATCC 26185 can effectively function as stand-alone enzymes in Escherichia coli. Appl Environ Microbiol. 2017;83(9):03133–16.

    Article  Google Scholar 

  14. Li Z, Chen X, Li J, et al. Functions of PKS genes in lipid synthesis of Schizochytrium sp by gene disruption and metabolomics analysis. Mar Biotechnol. 2018;20(6):792–802.

    Article  CAS  Google Scholar 

  15. Li Z, Meng T, Ling X, et al. Overexpression of malonyl-CoA: ACP transacylase in Schizochytrium sp to improve polyunsaturated fatty acid production. J Agric Food Chem. 2018;66(21):5382–91.

    Article  CAS  PubMed  Google Scholar 

  16. Shi Y, Chen Z, Li Y, et al. Function of ORFC of the polyketide synthase gene cluster on fatty acid accumulation in Schizochytrium limacinum SR21. Biotechnol Biofuels. 2021;14(1):163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang Z, Wang S, Feng Y, et al. Obtaining high-purity docosahexaenoic acid oil in Thraustochytrid Aurantiochytrium through a combined metabolic engineering strategy. J Agric Food Chem. 2021;69(35):10215–22.

    Article  CAS  PubMed  Google Scholar 

  18. Xue Z, Sharpe PL, Hong SP, et al. Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica. Nat Biotechnol. 2013;31(8):734–40.

    Article  CAS  PubMed  Google Scholar 

  19. Zhao X, Qiu X. Very long chain polyunsaturated fatty acids accumulated in triacylglycerol are channeled from phosphatidylcholine in Thraustochytrium. Front Microbiol. 2019;10:645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ren LJ, Chen SL, Geng LJ, et al. Exploring the function of acyltransferase and domain replacement in order to change the polyunsaturated fatty acid profile of Schizochytrium sp. Algal Res. 2018;29:193–201.

    Article  Google Scholar 

  21. Jenni S, Leibundgut M, Boehringer D, et al. Structure of fungal fatty acid synthase and implications for iterative substrate shuttling. Science. 2007;316(5822):254–61.

    Article  CAS  PubMed  Google Scholar 

  22. Zhu Z, Zhou YJ, Krivoruchko A, et al. Expanding the product portfolio of fungal type I fatty acid synthases. Nat Chem Biol. 2017;13(4):360–2.

    Article  CAS  PubMed  Google Scholar 

  23. Li J, Zheng Y, Yang WQ, et al. Enhancing the accumulation of lipid and docosahexaenoic acid in Schizochytrium sp by co-overexpression of phosphopantetheinyl transferase and omega-3 fatty acid desaturase. Biotechnol J. 2023;18(12):2300314.

    Article  CAS  Google Scholar 

  24. Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Bio. 2018;19(5):281–96.

    Article  CAS  Google Scholar 

  25. Martin CE, Oh CS, Jiang Y. Regulation of long chain unsaturated fatty acid synthesis in yeast. Biochim Biophys Acta. 2007;1771(3):271–85.

    Article  CAS  PubMed  Google Scholar 

  26. Ballweg S, Sezgin E, Doktorova M, et al. Regulation of lipid saturation without sensing membrane fluidity. Nat Commun. 2020;11(1):756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Han X, Liu Y, Chen Z. Zinc finger protein LipR represses docosahexaenoic acid and lipid biosynthesis in Schizochytrium sp. Appl Environ Microbiol. 2022;88(6): e0206321.

    Article  PubMed  Google Scholar 

  28. Liu Y, Han X, Dai Y, et al. bZIP transcription factor FabR: Redox-dependent mechanism controlling docosahexaenoic acid biosynthesis and H(2)O(2) stress response in Schizochytrium sp. Free Radic Biol Med. 2023;210:246–57.

    Article  PubMed  Google Scholar 

  29. He L, Guo W, Li J, et al. Two dominant selectable markers for genetic manipulation in Neurospora crassa. Curr Genet. 2020;66(4):835–47.

    Article  CAS  PubMed  Google Scholar 

  30. Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem. 1959;31(3):426–8.

    Article  CAS  Google Scholar 

  31. Han X, Zhao Z, Wen Y, et al. Enhancement of docosahexaenoic acid production by overexpression of ATP-citrate lyase and acetyl-CoA carboxylase in Schizochytrium sp. Biotechnol Biofuels. 2020;13:131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Patel A, Rova U, Christakopoulos P, et al. Simultaneous production of DHA and squalene from Aurantiochytrium sp grown on forest biomass hydrolysates. Biotechnol Biofuels. 2019;12:255.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Liang YN, Tang TY, Umagiliyage AL, et al. Utilization of sorghum bagasse hydrolysates for producing microbial lipids. Appl Energ. 2012;91(1):451–8.

    Article  CAS  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

ZC and YNL developed the idea for the study. YNL, XH, ZCC and YHY performed the experiments. ZC and YNL analyzed the results and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Zhi Chen.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors have read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

13068_2024_2524_MOESM1_ESM.pptx

Supplementary material 1. Figure S1. Construction of WFAS. Figure S2. Phenotypes of WT, WFAS, and DPKSA. Figure S3. Confocal microscopy images of Nile red-stained cells grown in fermentation medium for 72 h. Figure S4. Schematic representation of insertion inactivation of orfA. Figure S5. Aerobic and anaerobic pathways for VLCPUFA biosynthesis in Schizochytrium sp. ATCC20888. Figure S6. Effects of decreased expression of fas or disruption of orfA on lipid accumulation. Figure S7. Construction of orfAB overexpression strain. Figure S8. Effect of enhanced fatty acid synthesis PKS pathway on lipid accumulation. Figure S9. PCR verification of overexpression mutants.

Supplementary material 2. Table S1. Strains and plasmids used in this study. Table S2. Primers used in this study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Han, X., Chen, Z. et al. Selectively superior production of docosahexaenoic acid in Schizochytrium sp. through engineering the fatty acid biosynthetic pathways. Biotechnol Biofuels 17, 75 (2024). https://doi.org/10.1186/s13068-024-02524-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13068-024-02524-2

Keywords